Digital Polymerase Chain Reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of nucleic acid to a detectable level. This has evoked a need of better techniques to assess the minute quantities of DNA or RNA. dPCR is more sensitive and reliable technique with improved ability to quantify the absolute amount of nucleic acid.
The global digital PCR market size is forecast to reach USD 799.1 million by 2026, attributed to the increasing prevalence of infectious diseases and genetic disorders worldwide.
Global single-cell analysis market is set to witness a healthy CAGR of 17.5% in the forecast period of 2019 to 2026. The report contains data of the base year 2018 and historic year 2017. This rise in the market can be attributed due to increasing adoption of single-cell analysis for diagnostic.
Data Bridge Market Research analyses that the digital polymerase chain reaction (PCR) market which was USD 0.75 billion in 2022, is expected to reach USD 1.49 billion by 2030, at a CAGR of 9.0% during the forecast period 2023 to 2030. https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-pcr-market
According to the latest research report by IMARC Group, The global histology and cytology market size reached US$ 16.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.92% during 2024-2032. More Info:- https://www.imarcgroup.com/histology-cytology-market
The Global Polymerase Chain Reaction Technologies Market Size was valued at $7 billion in 2016, and is estimated to reach $11 billion by 2023, growing at a CAGR of 6.9% during the forecast period Full Report: https://kbvresearch.com/polymerase-chain-reaction-technologies-market/
The Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was estimated at $4876 million in 2020, and is projected to grow at a CAGR of 9.2% during the forecast period 2021-2026.
Looking forward, the magnetic beads market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/magnetic-beads-market
Latest research report “Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2jWmqpS Request a Sample: http://bit.ly/2ku0R0f
Artificial Intelligence is the future of the healthcare industry. This could be attributed to improvements in diagnostic precision as there would be automatic assistance regarding clinical operation, workforce, and quantitative imaging. The Digital PCR Market report by Persistence Market Research emphasizes on the inflow of artificial intelligence therein and also the medications (pharmaceuticals) to be rendered. Precise diagnostics leads to precise rendition of drugs.
Polymerase Chain Reaction Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study"
A newly published report by Market Statsville Group (MSG), title dGlobal Pharmacogenomics Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global Pharmacogenomics market will showcase an impressive CAGR from 2024 to 2033. The comprehensive Pharmacogenomics market research study highlights market dynamics, value chain analysis, regulatory framework, growing investment hotspots, competitive landscape, geographical landscape, and extensive market segments.
The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032. The growth in the global liquid biopsy market is expected to be driven by increasing adoption of NGS in various research fields, advancement in NGS, and increase in the adoption of personalized medicine.
The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
Enhanced focus on accuracy and reliability of pneumococcal testing continues to shape the market. As reliability of diagnostic tests remain the backbone of pathogen-directed treatment, increased emphasis on enhanced patient care is driving the growth of pneumococcal testing market. Proliferation of diagnostic tests in both developing and developed economies is the growth engine of pneumococcal testing market, according to a new study of Future Market Insights (FMI). The study finds that global pneumococcal testing market surpassed a billion-dollar revenues in 2019. Prolific demand for analyzers is stimulating market growth, with consumables closing in. Moreover, immunofluorescence is gaining paramount importance in pneumococcal testing market.
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030. Factors driving the growth of the market including advancement of sequencing technologies, rising prevalence of chronic diseases, growing demand for preventive care, and shifting the significance in medicine from reaction to prevention.
The global pharmacogenomics services market is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031.
The global PCR and realtime PCR testing market is expected to decline from $22.53 billion in 2020 to $9.98 billion in 2021 at a compound annual growth rate (CAGR) of -55.7%. The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to reach $13.82 billion in 2025 at a CAGR of 8.5%.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
According to the Market Statsville Group, the global genotyping market size was valued at USD 19,952.6 million in 2021 and is projected to grow at a CAGR of 27.3% to reach USD 137,602.6 million by 2030.
Bharat Book Bureau provides the report; on “Liquid Biopsy Research Tools, Services and Diagnostics Global Markets” This report global market is analyzed by application, biomarker type, analysis platform, analysis purpose and geographic region. https://www.bharatbook.com/diagnostics-market-research-reports-216402/liquid-biopsy-research-tools-services-diagnostics.html
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100000817 According to a new market research study titled ‘dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology, Product, and Application. The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2018-2025. The report highlights the trends prevalent in the global dPCR and qPCR market and the factors driving the market along with those that act as deterrents to its growth.
A new study titled “Pharmacogenomics Market Size 2022”, published by Market Statsville Group (MSG), provides information on regional and global markets. MSG expects the global Pharmacogenomics market will showcase an impressive CAGR from 2022 to 2030.
According to the latest research report by IMARC Group, The global magnetic beads market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.41% during 2023-2028. More Info:- https://www.imarcgroup.com/magnetic-beads-market
In 2022, the minimal residual disease testing market was worth around USD 1,156.8 million, and it is projected to advance at a 15.1% CAGR from 2022 to 2030
The molecular point of care diagnostics market is estimated to grow at a CAGR of 14.05% and expected to reach $7398.82 million by 2028. Get a Free Sample Report.
Global life science instrumentation market is projected to reach US$ 90 Bn by 2027, expanding at a single digit CAGR during the forecast period. Rise in prevalence and incidence rates of infectious diseases, high R&D investment by major players, and technological advancements are anticipated to drive the global market.
Bharat Book Bureau Provides the Trending Market Research Report; on “Global Liquid Biopsy Market Forecast 2022”, (https://www.bharatbook.com/diagnostics-market-research-reports-216402/liquid-biopsy-research-tools-services-diagnostics-global.html)The report provides a comprehensive discussion of liquid diagnostic assay technologies, clinical applications, business structure, liquid diagnostic assay funding initiatives, world markets, patent standing and firms.
Global PCR Devices Market By Technology (Digital PCR, Real-time PCR), By Product Type (Instrument, Reagent, Consumables, Others), By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others), By End User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)- Industry Trends and Forecast to 2024
The global in-vitro diagnostics market was valued at around $56 billion in 2017.The USA was the largest country in the market in 2017, accounting for under 21% market share. Read More: https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report-2018
Global PCR market is expected to reach a market value of about US$ 7.0 Bn by the end of 2026, expanding at a high single digit CAGR during the forecast period.
Next-Generation Gynecological Cancer Diagnostics market to grow at a significant CAGR of 10.07% during 2020-2031.The Market is expected to reach $5,657.7 Million by 2031. Next-Generation Gynecological Cancer Diagnostics market report by BIS Research provides deep market insight, industry analysis, trends & forecast to 2031 that will help your business to grow.
Analysts at Future Market Insights find that the global BRCA Mutation-Positive Ovarian Cancer market has been evolving at a CAGR of xx% during the historic period 2015-2019. The market study suggests that the global market size of BRCA Mutation-Positive Ovarian Cancer is projected to reach ~US$ xx Mn/Bn by the end of 2030 with a CAGR of xx% over the stipulated timeframe 2020-2030.
Global Single-Use Bioreactors Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing research and development (R&D) activities, collaborations, and strategic partnerships along with soaring demand for new vaccines, therapeutics, and rising chronic and infectious diseases. ➡
Typed in 10-pitch font, one human sequence would stretch for more than 5,000 miles. ... suggested myostatin as a candidate gene to Grobet et al., who identified an 11 ...
Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”. This edition portrays the inspiring stories of the listed pre-eminent organizations that are shaping the future of healthcare through innovation and dedication.
More sophisticated/automated (high throughput) screening has increased lead ... The goal of Genomics is to unravel the genetic basis of health and disease ...